What is HSBC's price target for ZY?

HSBC's latest stated price target for Zymergen Inc. (ZY) is $6.50, from its action on Jan 12, 2022.

What is HSBC's rating on ZY?

HSBC rates ZY Hold, a neutral rating, as of Jan 12, 2022.

When did HSBC last change its view on ZY?

On Jan 12, 2022, HSBC upgrades to Hold from Reduce, price target $6.50.

HSBC ZY price target and rating history

HSBC rates Zymergen Inc. (ZY) Hold with a $6.50 price target, as of its latest action on Jan 12, 2022. It has published 3 rating actions on ZY since July 2021, including 1 upgrade and 1 downgrade.

Current rating: Hold
Price target: $6.50
Median target, all firms: Too few
Actions on ZY: 3

HSBC price target on ZY

HSBC price target on ZY, each point a stated target, July 2021 to January 2022.

Every HSBC rating on ZY

Jan 12, 2022
UpgradeHSBC upgrades to Hold from Reduce, price target $6.50
Aug 4, 2021
DowngradeHSBC downgrades to Reduce from Hold, price target $8
Jul 6, 2021
InitiateHSBC starts coverage at Hold, price target $42

Questions about HSBC and ZY

What is HSBC's price target for ZY?: HSBC's latest stated price target for Zymergen Inc. (ZY) is $6.50, from its action on Jan 12, 2022.
What is HSBC's rating on ZY?: HSBC rates ZY Hold, a neutral rating, as of Jan 12, 2022.
When did HSBC last change its view on ZY?: On Jan 12, 2022, HSBC upgrades to Hold from Reduce, price target $6.50.

More ZY rating histories

TD Cowen3

All HSBC ratings ZY news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.